About Paul Borm

Paul Borm is expert in Toxicology and entrepreneur in Life Sciences and Medical Technology and. During his 25-year academic career in Toxicology (Utrecht, Maastricht, Düsseldorf) he conducted research into lung and cardiac diseases with a clear focus on occupational health exposure. In 2004 he co-founded a high-impact journal (PFT) for particle toxicology and he is the author of close to 200 publications. For 20 years now, Nanotechnologies feed his activities on regional and global level, and provide inspiration for both his research and business activities. In 2011 he founded Nano4Imaging GmbH in Aachen which focuses on improvement of cardiovascular diagnosis and interventions using MRI, and Borm is responsible for clinical evaluation, post-marketing surveillance and MDR related issues. Borm acts as (strategic) consultant for several global companies and associations in the field chemicals, minerals and particles. In 2019 Borm has initiated, guided, organized, moderated and published a consensus opinion workshop on PSLT for all relevant stakeholders. Finally, he acts as a consultant in toxicology, expert assessments and due diligence on strategic and operational level. He still teaches Toxicology at post-graduate courses in NL and Germany, and medical imaging at Dusseldorf University.

Advances in Medical Imaging- a home game

A home game this time. From our offices at the Dusseldorf Life Science Centres we are proud to co-organize a webinar on Advances on Medical Imaging using MRI and also include some time for the role of artificial intelligence in the proces of medical imaging. What progress has been made [...]

2022-04-25T14:07:39+02:00April 25, 2022|Categories: Blogs|

marker device visibility for 3-T interventions

Optimised passive marker device visibility and automatic marker detection for 3-T MRI-guided endovascular interventions: a pulsatile flow phantom study Passive paramagnetic markers on magnetic resonance imaging (MRI)-compatible endovascular devices induce susceptibility artifacts, enabling MRI-visibility and real-time MRI-guidance. Optimised visibility is crucial for automatic detection and device tracking but depends [...]

goodbye to ficks law

Goodbye to Fick's law It has always been assumed but never proven that iCMR gives an incremental value by providing more accurate flow quantification. In Dallas Childrens/UTSW interventional MRI is now standard procedure in young adults. Therefore they conducted a study in 30 patients with CHD and conducted both right [...]

2021-12-14T17:57:57+01:00November 29, 2021|Categories: Publications|Tags: , , |
Go to Top